India · Delayed Price · Currency is INR Balaxi Pharmaceuticals Statistics
Total Valuation
NSE:BALAXI has a market cap or net worth of INR 1.31 billion. The enterprise value is 1.74 billion.
| Market Cap | 1.31B |
| Enterprise Value | 1.74B |
Important Dates
The next estimated earnings date is Tuesday, July 28, 2026.
| Earnings Date | Jul 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:BALAXI has 55.21 million shares outstanding. The number of shares has decreased by -1.29% in one year.
| Current Share Class | 55.21M |
| Shares Outstanding | 55.21M |
| Shares Change (YoY) | -1.29% |
| Shares Change (QoQ) | +9.59% |
| Owned by Insiders (%) | 4.53% |
| Owned by Institutions (%) | n/a |
| Float | 9.57M |
Valuation Ratios
The trailing PE ratio is 91.04.
| PE Ratio | 91.04 |
| Forward PE | n/a |
| PS Ratio | 0.48 |
| PB Ratio | 0.52 |
| P/TBV Ratio | 0.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 122.64 |
| EV / Sales | 0.64 |
| EV / EBITDA | 20.38 |
| EV / EBIT | 27.26 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.05, with a Debt / Equity ratio of 0.23.
| Current Ratio | 4.05 |
| Quick Ratio | 2.42 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 6.76 |
| Debt / FCF | -1.39 |
| Interest Coverage | 1.63 |
Financial Efficiency
Return on equity (ROE) is 0.59% and return on invested capital (ROIC) is 0.62%.
| Return on Equity (ROE) | 0.59% |
| Return on Assets (ROA) | 1.23% |
| Return on Invested Capital (ROIC) | 0.62% |
| Return on Capital Employed (ROCE) | 2.32% |
| Weighted Average Cost of Capital (WACC) | 6.16% |
| Revenue Per Employee | 4.50M |
| Profits Per Employee | 23,615 |
| Employee Count | 600 |
| Asset Turnover | 0.83 |
| Inventory Turnover | 1.86 |
Taxes
In the past 12 months, NSE:BALAXI has paid 38.76 million in taxes.
| Income Tax | 38.76M |
| Effective Tax Rate | 73.23% |
Stock Price Statistics
The stock price has decreased by -51.76% in the last 52 weeks. The beta is 0.70, so NSE:BALAXI's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | -51.76% |
| 50-Day Moving Average | 25.22 |
| 200-Day Moving Average | 29.35 |
| Relative Strength Index (RSI) | 46.75 |
| Average Volume (20 Days) | 27,554 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:BALAXI had revenue of INR 2.70 billion and earned 14.17 million in profits. Earnings per share was 0.26.
| Revenue | 2.70B |
| Gross Profit | 1.19B |
| Operating Income | 63.75M |
| Pretax Income | 52.93M |
| Net Income | 14.17M |
| EBITDA | 85.28M |
| EBIT | 63.75M |
| Earnings Per Share (EPS) | 0.26 |
Balance Sheet
The company has 145.59 million in cash and 576.49 million in debt, with a net cash position of -430.90 million or -7.81 per share.
| Cash & Cash Equivalents | 145.59M |
| Total Debt | 576.49M |
| Net Cash | -430.90M |
| Net Cash Per Share | -7.81 |
| Equity (Book Value) | 2.49B |
| Book Value Per Share | 44.71 |
| Working Capital | 1.89B |
Cash Flow
In the last 12 months, operating cash flow was -45.00 million and capital expenditures -369.25 million, giving a free cash flow of -414.24 million.
| Operating Cash Flow | -45.00M |
| Capital Expenditures | -369.25M |
| Depreciation & Amortization | 21.53M |
| Net Borrowing | 40.62M |
| Free Cash Flow | -414.24M |
| FCF Per Share | -7.50 |
Margins
Gross margin is 44.16%, with operating and profit margins of 2.36% and 0.52%.
| Gross Margin | 44.16% |
| Operating Margin | 2.36% |
| Pretax Margin | 1.96% |
| Profit Margin | 0.52% |
| EBITDA Margin | 3.16% |
| EBIT Margin | 2.36% |
| FCF Margin | n/a |
Dividends & Yields
NSE:BALAXI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.29% |
| Shareholder Yield | 1.29% |
| Earnings Yield | 1.08% |
| FCF Yield | -31.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 30, 2024. It was a forward split with a ratio of 5.
| Last Split Date | May 30, 2024 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |